BiotechTube
Qualicaps

Qualicaps

Whitsett, United States· Est.
qualicaps.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $430M

Overview

Qualicaps is a long-established, global provider of hard capsule delivery systems and related manufacturing equipment for the pharmaceutical and consumer health sectors. The company's core value proposition is its 'Engineered to Perform' philosophy, focusing on precision, functionality, and partnership throughout the product lifecycle. In October 2023, Qualicaps was acquired by Roquette, a move that strengthens its global footprint and portfolio of oral dosage solutions within a larger parent organization.

Drug Delivery

Technology Platform

Design, engineering, and manufacturing of two-piece hard capsules (including plant-based) and integrated processing equipment for pharmaceutical and nutraceutical solid oral dosage forms and dry powder inhalers.

Funding History

1
Total raised:$430M
Acquisition$430M

Opportunities

Growth is driven by increasing global demand for oral solid dosage forms, the trend towards plant-based and specialty capsules, and the need for integrated manufacturing solutions.
The acquisition by Roquette provides expanded global reach and R&D synergies.

Risk Factors

Key risks include supply chain vulnerability for raw materials, intense competition in the capsule market, integration challenges following the Roquette acquisition, and stringent regulatory compliance requirements for pharmaceutical suppliers.

Competitive Landscape

Qualicaps competes in the global hard capsule and filling equipment market against major players like Lonza (Capsugel) and ACG. Its differentiation is based on its 'Engineered to Perform' philosophy, plant-based expertise, and integrated offering of capsules, equipment, and technical services.

More companies in Drug Delivery & Formulation →More companies in United States →